Clinical progression in early and late stages of disease in a cohort of individuals infected with human immunodeficiency virus-2 in Guinea-Bissau

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 4, 2003, Pages 265-272

  Norrgren, Hans ^a,b   Da Silva, Zacarias ^a   Biague, Antonio ^a   Andersson, Sören ^c   Biberfeld, Gunnel ^c  

^a National Public Health Laboratory   (Guinea-Bissau)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GUINEA-BISSAU; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; POPULATION RESEARCH; PROGNOSIS; SEROCONVERSION; SEROLOGY; STAGING; SYMPTOMATOLOGY; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; CD4-CD8 RATIO; COHORT STUDIES; DEVELOPING COUNTRIES; DISEASE PROGRESSION; FEMALE; GUINEA-BISSAU; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-2; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROBABILITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 0038760843     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310000210     Document Type: Article

References (31)

1. Clavel F, Guétard D, Brun-Vézinet F, Chamaret S, Rey M-A, Santos-Ferreira MO, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986; 233: 343-6.
2. Schim van der Loeff MF, Aaby P. Towards a better understanding of the epidemiology of HIV-2. AIDS 1999; 13: S69-84.
3. De Cock KM, Adjorlolo G, Ekpini E, Sibailly T, Kouadio J, Maran M, et al. Epidemiology and transmission of HIV-2: why there is no HIV-2 pandemic. JAMA 1993; 270: 2083-6.
4. Larsen O, da Silva Z, Sandström A, Andersen PK, Andersson S, Poulsen A-G, et al. Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau. AIDS 1998; 12: 1707-14.
5. Norrgren H, Andersson S, Biague AJ, da Silva Z, Dias F, Nauclér A, Biberfeld G. Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, West Africa: no protection of HIV-2 against HIV-1 infection. AIDS 1999; 13: 701-7.
6. Bock PJ, Markovitz DM. Infection with HIV-2. AIDS 2001; 15(Suppl 5): S35-45.
7. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1991; 126: 946-54.
8. Anonymous. Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaboration Group. AIDS Res Hum Retroviruses 2000; 16: 1123-33.
9. Ariyoshi K, Jaffar S, Alabi AS, Berry N, Schim van der Loeff M, Sabally S, et al. Plasma RNA viral load predicts the rate of CD4 cell decline and death in HIV-2 infected patients in West Africa. AIDS 2000; 14: 339-44.
10. Popper SJ, Sankale JL, Thior T, Siby T, Marlink RG, Mboup S, et al. Antibodies to the HIV type 2 core protein p26 and Vpx: association with disease progression. AIDS Res Hum Retroviruses 1998; 14: 1157-62.
11. Kestens L, Brattegaard K, Adjorlolo G, Ekpini E, Sibailly T, Diallo K, et al. Immunological comparison of HIV-1-, HIV-2-and dually-reactive women delivering in Abidjan, Côte d'Ivoire. AIDS 1992; 6: 803-7.
12. Ricard D, Wilkins A, N'Gum PT, Hayes R, Morgan G, Da Silva AP, Whittle H. The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 1994; 8: 977-82.
13. Norrgren H, da Silva ZJ, Andersson S, Biague AJ, Dias F, Biberfeld G, Nauclér A. Clinical features, immunological changes and mortality in a cohort of HIV-2 infected individuals in Bissau, Guinea-Bissau. Scand J Infect Dis 1998; 30: 323-9.
14. Centers for Disease Control. Classification system for human T-1 lymphocytic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep 1986; 35: 334-9.
15. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265: 1587-90.
16. World Health Organization. Acquired immunodeficiency syndrome (AIDS). Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990; 65: 221-4.
17. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS. MMWR Morb Mortal Wkly Rep 1992; 41: RR17.
18. Norrgren H, Andersson S, Nauclér A, Dias F, Johansson I, Biberfeld G. HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: Incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau. J Acquir Immune Defic Syndr 1995; 9: 422-8.
19. De Cock KM, Porter A, Kouadio J, Maran M, Lafontaine M-F, Gershy-Damet G-M, et al. Cross-reactivity on Western blots in HIV-1 and HIV-2 infections. AIDS 1991; 5: 859-63.
20. WHO Global Programme on AIDS. Proposed WHO criteria for interpretation of results from Western blot assay for HIV-1, HIV-2 and HTLV-I/HTLV-II. Wkly Epidemiol Rec 1990; 37: 281-3.
21. Poulsen A-G, Aaby P, Larsen O, Jensen H, Nauclér A, Lisse IM, et al. 9-year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet 1997; 349: 911-4.
22. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner H-U, Mulder DW, Whitworth JA. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997; 350: 245-50.
23. Malamba SS, Morgan D, Clayton T, Mayanja B, Okongo M, Whitworth J. The prognostic value of the World Health Organisation staging system for HIV infection and disease in rural Uganda. AIDS 1999; 13: 2555-62.
24. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JAG. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16: 597-603.
25. Anzala OA, Nagelkerke NJD, Bwayo JJ, Holton D, Moses S, Ngugi EN, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171: 686-9.
26. Medley GF, Anderson RM, Cox DR, Billard L. Incubation period of AIDS in patients infected via blood transfusion. Nature 1987; 328: 719-21.
27. Kelly GE, Stanley BS, Weller IVD. The natural history of human immunodeficiency virus infection: a five year study in a London cohort of homosexual men. Genitourin Med 1990; 66: 238-43.
28. Jaffar S, Wilkins A, Ngom PT, Sabally S, Corrah T, Bangali JE, et al. Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection. J Acquir Immune Defic Syndr 1997; 16: 327-32.
29. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings. Guidelines for a public health approach, executive summary Geneva: WHO; 2002.
30. Burcham J, Marmor M, Dubin N, Tindall B, Cooper DA, Berry G, Penny R. CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991; 5: 365-72.
31. Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa. Arch Intern Med 2000; 160: 3286-93.